Oral Abstracts
OA 17.01 Pemetrexed-Carboplatin Plus Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC: KEYNOTE-021 Cohort G Update

https://doi.org/10.1016/j.jtho.2017.09.427Get rights and content
Under an Elsevier user license
open archive

Cited by (0)